TOKYO: A major Japanese drugmaker said today it was investigating one death from kidney dysfunction potentially linked to health supplements recalled last week by the firm.
It comes a day after the drugmaker, Kobayashi Pharmaceutical, said it was aware of 26 cases of people being hospitalised in relation to the prescription-free supplements.
The three recalled products – “beni koji choleste help” and two similarly named supplements – contain an ingredient called “beni koji”, made by fermenting rice with yeast, which is supposed to lower levels of bad cholesterol.
“We’re now aware of one instance where there is a potential causal link between a death and our product,” Kobayashi Pharmaceutical said in a statement.
SPONSORED CONTENT Sabah revenue hits RM6.97 billion: Hajiji says GRS State Government may see full term Kota Kinabalu: The Sabah Government continued its momentum in managing the economy in line with the commitment and spirit of the Sabah Maju Jaya (SMJ) when it posted record high state revenue of RM6.973 billion last year. Read more “We are currently investigating the link, and what happened,” it said, offering its “deepest apologies”.
The Osaka-based drugmaker voluntarily recalled the three products on Friday following customer complaints about kidney problems.
It said yesterday that it had not reached a conclusion on a link between the health problems and its supplements, but said an analysis had found a possibility that the beni koji contained “ingredients we had not intended to include”.
Kobayashi Pharmaceutical says it has supplied beni koji to around 50 other firms worldwide, according to public broadcaster NHK.
Japanese media reports said Kobayashi executives would visit the victim’s family today.
* Follow us on Instagram and join our Telegram and/or WhatsApp channel(s) for the latest news you don't want to miss.
* Do you have access to the Daily Express e-paper and online exclusive news? Check out subscription plans available.
